Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 450 of 2529 entries
View as:

Pharmacokinetics (PK) of TKI258 in Cancer Patients With Normal and Impaired Hepatic Function

Phase: N/A Priority: Normal
NCT ID: NCT01443481 Org: User:
Start: 11/30/11 End: 10/31/14 Due: 10/31/15

Efficacy and Safety of Intravenous and Subcutaneous Secukinumab in Moderate to Severe Chronic Plaque-type Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT01412944 Org: User:
Start: 12/31/11 End: 04/30/13 Due: 04/30/14

An Extension Trial to a Phase I Dose Escalation Study of Gimatecan Administered Orally 5 Consecutive Days to Japanese Patients With Advanced Solid Tumor

Phase: N/A Priority: Normal
NCT ID: NCT00441610 Org: User:
Start: 01/31/07 End: - Due: -

Efficacy and Safety of Zoledronic Acid for the Treatment of Osteoporosis in Men

Phase: N/A Priority: Normal
NCT ID: NCT00097825 Org: User:
Start: 04/30/04 End: 08/31/07 Due: 08/31/08

Adaptive-design Dose Finding Study to Assess the Antiviral Efficacy and Safety of NIM811 Administered in Combination With Standard of Care (SOC) in Relapsed Hepatitis C Virus 1 (HCV-1) Infected Patients

Phase: N/A Priority: Normal
NCT ID: NCT00983060 Org: User:
Start: 09/30/09 End: - Due: -

Safety and Efficacy of AIN457 in Noninfectious Uveitis

Phase: N/A Priority: Normal
NCT ID: NCT00685399 Org: User:
Start: 06/30/08 End: 09/30/13 Due: 09/30/14

Real-world Experience With Lutetium Vipivotide Tetraxetan in Metastatic Castration Resistant Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06517719 Org: User:
Start: 09/04/24 End: 02/01/28 Due: 02/01/29

A Study of Select Drug Combinations in Adult Patients With Advanced/Metastatic BRAF V600 Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04294160 Org: User:
Start: 07/22/20 End: 09/25/24 Due: 09/25/25

Nilotinib Treatment-free Remission Study in CML (Chronic Myeloid Leukemia) Patients

Phase: N/A Priority: Normal
NCT ID: NCT01784068 Org: User:
Start: 03/19/13 End: 01/24/25 Due: 01/24/26

A Clinical Study to Evaluate the Safety and Effectiveness of Inclisiran Sodium in Indian Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia

Phase: N/A Priority: Normal
NCT ID: NCT06386419 Org: User:
Start: 11/12/24 End: 02/27/26 Due: 02/27/27

Concentration of Ofatumumab in the Breast Milk of Lactating Women With Relapsing Forms of Multiple Sclerosis

Phase: N/A Priority: Normal
NCT ID: NCT06444113 Org: User:
Start: 11/25/24 End: 02/23/27 Due: 02/23/28

QVA Mechanistic Efficacy Study (Receptor Effects, Etc)

Phase: N/A Priority: Normal
NCT ID: NCT02634983 Org: User:
Start: 06/03/16 End: 09/26/17 Due: 09/26/18

Effect of NVA237 on Exercise Endurance in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Phase: N/A Priority: Normal
NCT ID: NCT01154127 Org: User:
Start: 06/30/10 End: 02/28/11 Due: 02/28/12

Efficacy and Safety of Everolimus (RAD001) in Patients of All Ages With Subependymal Giant Cell Astrocytoma Associated With Tuberous Sclerosis Complex (TSC)(EXIST-1)

Phase: N/A Priority: Normal
NCT ID: NCT00789828 Org: User:
Start: 08/31/09 End: 10/31/14 Due: 10/31/15

A Multicenter Study of Continued Current Therapy vs Transition to Ofatumumab After Neurofilament (NfL) Elevation

Phase: N/A Priority: Normal
NCT ID: NCT05090371 Org: User:
Start: 03/02/22 End: 12/31/26 Due: 12/31/27

Long-term Safety, Tolerability and Effectiveness Study of Ofatumumab in Patients With Relapsing MS

Phase: N/A Priority: Normal
NCT ID: NCT03650114 Org: User:
Start: 12/28/18 End: 09/30/28 Due: 09/30/29

Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting

Phase: N/A Priority: Normal
NCT ID: NCT01318941 Org: User:
Start: 03/31/11 End: 04/30/16 Due: 04/30/17

A Phase III Study to Investigate Efficacy, Safety and Tolerability of Iptacopan Compared With Placebo in Participants Aged 18 to 75 Years With gMG.

Phase: N/A Priority: Normal
NCT ID: NCT06517758 Org: User:
Start: 07/31/24 End: 05/27/32 Due: 05/27/33

Asciminib Roll-over Study

Phase: N/A Priority: Normal
NCT ID: NCT04877522 Org: User:
Start: 08/30/22 End: 08/30/30 Due: 08/30/31

Open-label, Phase II Study of Stomatitis Prevention With a Steroid-based Mouthwash in Post-menopausal Women With Estrogen-receptor-positive (ER+), Human Epidermal Growth Factor Receptor 2 (HER2)- Metastatic or Locally Advanced Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02069093 Org: User:
Start: 05/31/14 End: 03/31/16 Due: 03/31/17

Single Arm, Open Label Trial With Iptacopan Treatment for 24 Weeks, in Patients on Stable Regimen of Anti-C5 Who Switch to Iptacopan.

Phase: N/A Priority: Normal
NCT ID: NCT05630001 Org: User:
Start: 04/24/23 End: 10/17/24 Due: 10/17/25

To Assess Safety, Tolerability and Efficacy of LJN452 in Patients With Primary Bile Acid Diarrhea.

Phase: N/A Priority: Normal
NCT ID: NCT02713243 Org: User:
Start: 01/16/16 End: 01/25/18 Due: 01/25/19

An Open-label Study of JSB462 (Luxdegalutamide) in Combination With Abiraterone in Adult Male Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)

Phase: N/A Priority: Normal
NCT ID: NCT06991556 Org: User:
Start: 07/30/25 End: 10/20/35 Due: 10/20/36

A 12 Week Treatment, Multi-center, Randomized, Double-blind, Parallel-group, Placebo and Active Controlled Study to Assess the Efficacy, Safety, and Tolerability of Indacaterol Maleate / Glycopyrronium Bromide in COPD Patients With Moderate to Severe Airflow Limitation.

Phase: N/A Priority: Normal
NCT ID: NCT01727141 Org: User:
Start: 11/30/12 End: 02/28/14 Due: 02/28/15

Effect of Zoledronic Acid on Bone Metabolism in Patients With Bone Metastasis and Prostate or Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00334139 Org: User:
Start: 05/31/06 End: 07/31/09 Due: 07/31/10